Recent Finacing
Recent Raise
Cerapedics develops and commercializes a P-15 synthetic peptide platform and the i-FACTOR peptide-enhanced bone graft for orthopedic fusion, FDA-approved for ACDF and being studied for lumbar fusion.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Cerapedics.